In an effort to understand the extent to which health care providers feel responsible for their patients' medication adherence, UCLA researchers and colleagues conducted focus-group discussions with providers and recorded out-patient office visits with 100 patients taking a total of 410 medications. They also examined how adherence discussions were initiated between providers and patients.
The researchers found that providers felt responsible for assessing and addressing adherence but believed patients were ultimately responsible. The researchers also found that physician–patient interactions were conducted in a way that might address adherence for 62 percent of the 410 medications; these interactions included simple inquiries about adherence for 31.5 percent of the medications but in-depth questions about adherence for only 4.3 percent of the medications. Patients spontaneously disclosed their non-adherence in 51 percent of 39 identified instances of non-adherence.
Authors included Derjung M. Tarn, Thomas J. Mattimore and Neil S. Wenger of UCLA; Douglas S. Bell of UCLA and the RAND Corp.; and Richard L. Kravitz of UC Davis. JOURNAL: The research is published in the June issue of the Journal of the American Geriatrics Society.
The study was funded by the Robert Wood Johnson Foundation (grant 034384), the Agency for Healthcare Research and Quality (grant 1U18HS016391), a UCLA Mentored Clinical Scientist Development Award (5K12AG001004), and the UCLA Older Americans Independence Center (NIH's Natoinal Institute on Aging, grant P30-AG028748).
Advertise with us - Download World Pharma News' Media Pack Read more
August marks National Psoriasis Awareness Month, an opportunity to raise awareness about psoriasis, a skin disease that affects nearly 7.5 million Americans. For those living with this condition, finding information Read more
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, Read more
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in Read more
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving Read more
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better Read more
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: Read more
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 Read more
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth Read more